| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 64.769 | 96.877 | 136.125 | 153.652 | 181.424 | 190.451 | 231.245 | 245.550 | 289.501 | 318.810 |
| Total Income - EUR | 65.455 | 97.368 | 136.604 | 154.040 | 182.069 | 190.454 | 231.248 | 245.758 | 289.504 | 325.397 |
| Total Expenses - EUR | 14.434 | 28.711 | 44.512 | 54.301 | 73.716 | 100.744 | 108.456 | 121.600 | 116.405 | 150.583 |
| Gross Profit/Loss - EUR | 51.021 | 68.657 | 92.092 | 99.739 | 108.354 | 89.710 | 122.793 | 124.159 | 173.099 | 174.814 |
| Net Profit/Loss - EUR | 49.058 | 65.896 | 90.726 | 98.199 | 106.533 | 88.119 | 120.526 | 121.750 | 170.638 | 165.247 |
| Employees | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Histomedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 13.452 | 17.694 | 17.120 | 13.813 | 10.590 | 8.144 | 6.660 | 3.069 |
| Current Assets | 49.873 | 72.379 | 84.413 | 96.497 | 104.765 | 118.298 | 156.934 | 138.934 | 245.472 | 275.558 |
| Inventories | 431 | 2.419 | 2.464 | 3.966 | 7.330 | 13.209 | 17.024 | 7.503 | 10.449 | 30.728 |
| Receivables | 1.512 | 695 | 5.570 | 5.171 | 6.045 | 7.371 | 15.023 | 98.752 | 56.682 | 182.162 |
| Cash | 47.930 | 69.265 | 76.379 | 87.360 | 91.390 | 97.717 | 124.887 | 32.679 | 178.342 | 62.668 |
| Shareholders Funds | 49.300 | 66.136 | 90.962 | 98.430 | 106.760 | 88.342 | 120.744 | 121.969 | 209.350 | 165.464 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 573 | 6.243 | 7.026 | 15.760 | 15.635 | 44.108 | 46.780 | 25.109 | 42.782 | 113.163 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Histomedica Srl